Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Atherosclerotic Plaque Composition: Analysis With Multicolor CT And Targeted Gold Nanoparticles.

D. Cormode, E. Roessl, A. Thran, T. Skajaa, R. Gordon, J. Schlomka, V. Fuster, E. Fisher, W. Mulder, R. Proksa, Z. Fayad
Published 2010 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
PURPOSE To investigate the potential of spectral computed tomography (CT) (popularly referred to as multicolor CT), used in combination with a gold high-density lipoprotein nanoparticle contrast agent (Au-HDL), for characterization of macrophage burden, calcification, and stenosis of atherosclerotic plaques. MATERIALS AND METHODS The local animal care committee approved all animal experiments. A preclinical spectral CT system in which incident x-rays are divided into six different energy bins was used for multicolor imaging. Au-HDL, an iodine-based contrast agent, and calcium phosphate were imaged in a variety of phantoms. Apolipoprotein E knockout (apo E-KO) mice were used as the model for atherosclerosis. Gold nanoparticles targeted to atherosclerosis (Au-HDL) were intravenously injected at a dose of 500 mg per kilogram of body weight. Iodine-based contrast material was injected 24 hours later, after which the mice were imaged. Wild-type mice were used as controls. Macrophage targeting by Au-HDL was further evaluated by using transmission electron microscopy and confocal microscopy of aorta sections. RESULTS Multicolor CT enabled differentiation of Au-HDL, iodine-based contrast material, and calcium phosphate in the phantoms. Accumulations of Au-HDL were detected in the aortas of the apo E-KO mice, while the iodine-based contrast agent and the calcium-rich tissue could also be detected and thus facilitated visualization of the vasculature and bones (skeleton), respectively, during a single scanning examination. Microscopy revealed Au-HDL to be primarily localized in the macrophages on the aorta sections; hence, the multicolor CT images provided information about the macrophage burden. CONCLUSION Spectral CT used with carefully chosen contrast agents may yield valuable information about atherosclerotic plaque composition.
This paper references
10.1161/ATVBAHA.108.165514
Iron oxide particles for atheroma imaging.
T. Tang (2009)
10.1161/01.CIR.103.3.415
Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits
S. Ruehm (2001)
Assessment of coronary artery disease by cardiac computed tomography: a scientifi c statement from the
Mj Budoff (2006)
10.1136/hrt.53.4.363
Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.
M. Davies (1985)
10.1109/NSSMIC.2009.5401581
Large area photon counting X-ray imaging arrays for clinical dual-energy applications
W. Barber (2009)
Photon counting x - ray detector with overrange logic control
JE Tkaczyk
10.1063/1.3151864
Ultrashort dead time of photon-counting InGaAs avalanche photodiodes
A. Dixon (2009)
10.1016/j.jacc.2008.08.034
Coronary computed tomography angiography: our time has come, but there are miles to go before we sleep.
J. Rumberger (2008)
Quantifi cation of obstructive and nonob - structive coronary lesions by 64 - slice computed tomography : a comparative study with quantitative coronary angiography and intravascular ultrasound
MJ Budoff (2005)
10.1161/01.ATV.14.1.133
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Y. Nakashima (1994)
10.1161/CIRCULATIONAHA.106.178458
Assessment of Coronary Artery Disease by Cardiac Computed Tomography: A Scientific Statement From the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiolog
M. Budoff (2006)
10.1097/00004424-200204000-00009
A Surface-Modified Chylomicron Remnant-like Emulsion for Percutaneous Computed Tomography Lymphography: Synthesis and Preliminary Imaging Findings
E. Wisner (2002)
10.1016/J.JACC.2006.10.001
ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring By Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain
P. Greenland (2007)
10.1088/0031-9155/52/15/020
K-edge imaging in x-ray computed tomography using multi-bin photon counting detectors.
E. Roessl (2007)
10.1093/cvr/cvp209
Cardiovascular molecular imaging: an overview.
A. Saraste (2009)
10.1021/bc800520d
Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis.
D. Cormode (2009)
diovascular molecular imaging : an overview
J Sanz (2009)
Fibrin - specifi c spectral CT molecular imaging detects ruptured plaque without calcium interference [ abstr ]
D Pan (2008)
ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global car- References
P Greenland
10.1021/CR980441P
Metal-Based X-ray Contrast Media.
S. Yu. (1999)
10.1148/radiol.2492080560
Multienergy photon-counting K-edge imaging: potential for improved luminal depiction in vascular imaging.
S. Feuerlein (2008)
10.1016/0003-2697(78)90586-9
A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.
M. A. Markwell (1978)
10.1148/radiol.2463070989
Prospectively gated transverse coronary CT angiography versus retrospectively gated helical technique: improved image quality and reduced radiation dose.
J. Earls (2008)
10.1118/1.595999
X-ray attenuation properties of radiographic contrast media.
P. Lumbroso (1987)
Why do plaques rupture?
E. Falk (1992)
10.1021/NL8029114
Targeted gold nanoparticles enable molecular CT imaging of cancer.
R. Popovtzer (2008)
10.1088/0031-9155/21/5/002
Energy-selective reconstructions in X-ray computerized tomography.
R. Alvarez (1976)
10.1038/nature06803
Imaging of atherosclerotic cardiovascular disease
J. Sanz (2008)
782 radiology.rsna.org n Radiology: Volume 256: Number 3—September 2010 EXPERIMENTAL STUDIES: Multicolor CT Evaluation of Atherosclerotic Plaque Composition Cormode et al
10.1001/JAMA.291.2.210
Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals.
P. Greenland (2004)
10.1148/radiol.09090068
Focal cystic high-attenuation lesions: characterization in renal phantom by using photon-counting spectral CT--improved differentiation of lesion composition.
D. Boll (2010)
10.1007/BF02531316
Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots
G. Rouser (2006)
10.1021/nl801958b
Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform.
David P. Cormode (2008)
10.1016/J.ACRA.2005.02.016
Molecular Imaging of Human Thrombus with Computed Tomography
P. Winter (2005)
10.1002/smll.200701285
An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection.
D. Cormode (2008)
10.1016/0076-6879(86)28092-1
Reconstitution of high-density lipoproteins.
A. Jonas (1986)
10.1088/0031-9155/53/15/002
Experimental feasibility of multi-energy photon-counting K-edge imaging in pre-clinical computed tomography.
J. Schlomka (2008)
10.1148/radiology.219.2.r01ma19316
Molecular imaging.
R. Weissleder (2001)
10.1038/nrcardio.2009.172
Applications of cardiac multidetector CT beyond coronary angiography
K. Schuleri (2009)
10.1016/0076-6879(86)28086-6
[26] Electron microscopy of negatively stained lipoproteins
T. Forte (1986)
10.1038/nm1571
Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography
F. Hyafil (2007)
10.1259/0007-1285-46-552-1016
Computerized transverse axial scanning (tomography): Part I. Description of system. 1973.
G. Hounsfield (1995)
Computerized transverse axial scanning (tomography). 1. Description of system.
G. Hounsfield (1973)
10.1161/01.CIR.0000087480.94275.97
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
M. Naghavi (2003)
Electron microscopy of negatively stained lipoproteins.
T. Forte (1986)
10.1021/BC060186C
D-mannose-modified iron oxide nanoparticles for stem cell labeling.
D. Horák (2007)
10.1161/01.RES.0000119321.18573.5A
Seeing Within: Molecular Imaging of the Cardiovascular System
F. Jaffer (2004)
10.1016/j.jacc.2008.07.031
Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Indi
M. Budoff (2008)
10.1161/01.ATV.0000251503.35795.4f
Biomarkers of Atherosclerotic Plaque Instability and Rupture
W. Koenig (2007)
10.1016/J.JACC.2005.03.071
Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound.
A. Leber (2005)
A surfacemodifi ed chylomicron remnant-like emulsion for percutaneous computed tomography lymphography: synthesis and preliminary imaging fi ndings
Er Wisner (2002)



This paper is referenced by
10.1201/B19976-12
Potential Nanocarriers for Brain Drug Delivery
Mª Ángeles Holgado (2016)
10.1007/s12274-016-1174-y
An anisotropic propagation technique for synthesizing hyperbranched polyvillic gold nanoparticles
A. Schwartz-Duval (2016)
Spectral molecular imaging - a new modality
N. Anderson (2013)
10.5339/gcsp.2015.25
Utility of mass spectrometry for the diagnosis of the unstable coronary plaque
Shana S. Jacob (2015)
10.1038/srep12509
Evaluation of microbubble contrast agents for dynamic imaging with x-ray phase contrast
T. Millard (2015)
10.1021/jacs.8b05817
CT Imaging of Enzymatic Activity in Cancer Using Covalent Probes Reveal a Size-Dependent Pattern
Darya Tsvirkun (2018)
10.1007/978-3-319-53001-7_8
Atherosclerotic Plaque Imaging
Begoña Lavín Plaza (2018)
10.1016/j.ejmp.2020.11.012
Artificial intelligence in image reconstruction: The change is here.
Ramandeep Singh (2020)
Non-linear regularized decomposition of spectral x-ray projection images
N. Ducros (2016)
10.1016/J.NIMA.2010.11.072
Preclinical spectral computed tomography of gold nano-particles
E. Roessl (2011)
10.1002/adfm.201604213
In Vivo Micro-CT Imaging of Human Mesenchymal Stem Cells Labeled with Gold-Poly-L-Lysine Nanocomplexes.
Tae-Ho Kim (2017)
10.1007/s40336-013-0035-x
Advances in imaging vascular inflammation
N. Rajani (2013)
10.1201/B14802
Nanoparticles in bioimaging
J. L. P. Ucha (2013)
10.1007/s12265-011-9286-y
CT-Based Myocardial Perfusion Imaging-Practical Considerations: Acquisition, Image Analysis, Interpretation, and Challenges
V. C. Mehra (2011)
10.1038/nrd3578
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
M. Lobatto (2011)
10.1016/J.CCR.2018.03.007
Tailored lanthanide-doped upconversion nanoparticles and their promising bioapplication prospects
Lining Sun (2018)
10.1016/J.NIMA.2019.01.095
A wide energy range calibration algorithm for X-ray photon counting pixel detectors using high-Z sensor material
P. Zambon (2019)
10.1016/B978-0-323-26433-4.00002-6
Nano-based Drug Delivery and Diagnostic Systems
N. Kumar (2014)
10.1021/nn300392x
An early investigation of ytterbium nanocolloids for selective and quantitative "multicolor" spectral CT imaging.
D. Pan (2012)
10.1201/9781351228251-36
Small Animal X-ray Computed Tomography
C. Badea (2017)
10.1093/eurheartj/ehs067
Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque.
P. Camici (2012)
10.1007/s11910-014-0505-1
Nanotheragnostic Applications for Ischemic and Hemorrhagic Strokes: Improved Delivery for a Better Prognosis
T. Mouhieddine (2014)
10.1002/anie.201800838
Calcium Fluoride Nanocrystals: Tracers for In Vivo 19 F Magnetic Resonance Imaging.
I. Ashur (2018)
10.1016/J.IRBM.2017.06.002
Spectral CT Material Decomposition in the Presence of Poisson Noise: A Kullback–Leibler Approach
Tom Hohweiller (2017)
10.1098/rsta.2017.0110
Integrating nanomedicine and imaging
Carlos Pérez-Medina (2017)
10.1007/978-3-319-42169-8_17
Nanoparticles for Cardiovascular Imaging with CT
P. Chhour (2017)
10.1007/s40134-013-0017-9
Targeted Nanoparticles for Cardiovascular Molecular Imaging
G. Strijkers (2013)
10.1002/wnan.158
Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.
Shann S. Yu (2011)
10.15611/PN.2015.411.06
Nanotechnologia w biomedycynie
Benita Kostrzewa (2015)
Tools for Visualising MARS Spectral CT Datasets
A. Chernoglazov (2016)
10.1109/ISBI.2019.8759192
Human Knee Phantom for Spectral CT: Validation of a Material Decomposition Algorithm
S. Bussod (2019)
10.1002/cmmi.1573
Spectral CT: a technology primer for contrast agent development.
C. Schirra (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar